You have 9 free searches left this month | for more free features.

Primary Myelofibrosis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Ipoh, Perak, Malaysia
    Hospital Raja Permaisuri Bainun
Jul 18, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • (no location specified)
Mar 3, 2022

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Greifswald, Germany
  • +1 more
Jun 15, 2022

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

Recruiting
  • Myelofibrosis; Anemia
  • +5 more
  • Canton, Ohio
  • +1 more
Jun 10, 2022

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • (no location specified)
Jun 5, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Canton, Ohio
    Gabrail Cancer Center
Aug 3, 2022

Myelofibrosis Trial in Jinan (Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jul 3, 2022

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2021

Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
May 6, 2022

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Aomori, Japan
  • +15 more
Jan 19, 2022